ZebraSci

Temecula, United States Founded: 2009 • Age: 17 yrs Acquired By Becton Dickinson
Diversified contract research organization services are provided to clients.

About ZebraSci

ZebraSci is a Healthcare company based in Temecula (United States) founded in 2009 by Rob Schultheis, and was acquired by Becton Dickinson in August 2021. Diversified contract research organization services are provided to clients. Its chief executive, as recorded, is Adam Kalbermatten. Its website zebrasci.com draws about 40 thousand monthly visits. ZebraSci offers products and services including Container Closure Integrity Testing, Analytical Testing, Siliconization Testing, and Drug Combination Product Design. Its focus areas include Biopharma Outsourcing, CRO and Diversified. Its legal entity is ZEBRASCI, Inc. Its competitors include Charles River Laboratories, LabCorp and Cytel; 1 of its 3 listed competitors has raised funding.

Company details

ZebraSci was founded in 2009 by Rob Schultheis in Temecula, United States, where operations are based. As a contract research organization, a range of services in the life sciences sector is offered, including clinical and preclinical support. The company is led by CEO Adam Kalbermatten. Focus is placed on diversified solutions for pharmaceutical and biotech partners across the region.

  • Headquarters Temecula, United States
  • Founders Rob Schultheis
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website zebrasci.com
  • Social LinkedIn X Facebook
  • Acquired by Becton Dickinson (Aug 2021)
  • Legal Name Zebrasci, Inc.
Key Metrics

Products & Services of ZebraSci

ZebraSci offers a comprehensive portfolio of products and services, including Container Closure Integrity Testing, Analytical Testing, Siliconization Testing, and Drug Combination Product Design.

Container Closure Integrity Testing
Testing Service

Evaluates container barriers for sterile drug-device products.

Analytical Testing
Analysis Service

Conducts tests for drug combination product integrity.

Siliconization Testing
Material Analysis

Assesses siliconization in primary containers for devices.

Drug Combination Product Design
Design Service

Verifies design for drug-device integration and safety.

Investors in ZebraSci

ZebraSci has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include BD.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
BD is recognized for providing innovative medical technology solutions.
1897bd.comFranklin Lakes, United States
Premium access

Investor details for ZebraSci

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of ZebraSci

9 people are tracked at ZebraSci (3 in leadership, 6 in team).

NameRoleGroup
Rob Schultheis
FounderLeadership
Adam Kalbermatten
CEOLeadership
Christine Zawtocki Paisker
Quality Assurance DirectorLeadership
Richard Diorio Jr.
Combination Product Test EngineerTeam
Andrew Morris
Engineering TechnicianTeam
Nick Piro
Combination Product Engineer 2Team
Kayla Kaspar
Services Technology Development ManagerTeam
Judith Nieves Lacomba
Quality Assurance ManagerTeam
Jacob Carrara
Combination Product Service Operations ManagerTeam
Premium access

Complete people profiles for ZebraSci

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of ZebraSci

2 dated milestones of ZebraSci across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded ZebraSci is founded.
  2. Exit Acquired by Becton Dickinson.

Competitors of ZebraSci

ZebraSci has 3 listed competitors in our database, 1 of them funded. They include Charles River Laboratories, LabCorp and Cytel.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
criver.com1947Wilmington, United States21,400
Provider of drug discovery and preclinical development services
labcorp.com1969Burlington, United States9,321
Provider of laboratory tests for physicians
cytel.com1987Cambridge, United States$2M509
Data analysis and statistical solutions are provided for life sciences.
Premium access

Detailed competitors of ZebraSci

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of ZebraSci

The website of ZebraSci (zebrasci.com) receives about 39.6K visits a month.

  • Monthly visits
    39.6K

    ▲ 259.5% vs previous month

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as ZebraSci (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Zebrasci

Premium access

Complete news archive for ZebraSci

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ZebraSci

ZebraSci was founded in 2009.

ZebraSci is headquartered in Temecula, United States. It is registered at Temecula, California, United States.

Adam Kalbermatten is the CEO of ZebraSci, as recorded in our data.

ZebraSci was founded in 2009 by Rob Schultheis in Temecula, United States, where operations are based. As a contract research organization, a range of services in the life sciences sector is offered, including clinical and preclinical support. The company is led by CEO Adam Kalbermatten. Focus is placed on diversified solutions for pharmaceutical and biotech partners across the region.

ZebraSci's top competitors include LabCorp, Charles River Laboratories and Cytel.

ZebraSci offers Container Closure Integrity Testing, Analytical Testing, Siliconization Testing, and Drug Combination Product Design.

ZebraSci has 1 investor. Key investors include BD.

ZebraSci operates through Zebrasci, Inc..

Yes. ZebraSci was acquired by Becton Dickinson in August 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available